安科瑞(300286) - 2023 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2023 was CNY 230,181,960.88, representing an increase of 11.15% compared to CNY 207,092,988.61 in the same period last year[5] - Net profit attributable to shareholders was CNY 41,817,836.08, up 32.65% from CNY 31,526,052.10 year-on-year[5] - Basic earnings per share increased by 25.00% to CNY 0.20 from CNY 0.16 in the same period last year[5] - The company reported a total comprehensive income of CNY 36,758,659.66 for Q1 2023, compared to CNY 24,017,359.66 in the same period last year, an increase of 53.1%[23] - The net profit for Q1 2023 reached CNY 41,723,619.88, representing a 32.4% increase from CNY 31,526,052.10 in Q1 2022[23] Cash Flow and Liquidity - The net cash flow from operating activities improved by 37.41%, reaching CNY -38,556,018.90, compared to CNY -61,602,617.27 in the previous year[5] - Total cash inflow from operating activities was 262,996,355.44, compared to 230,543,486.02 in the previous year, reflecting a year-over-year increase of approximately 14%[26] - Cash outflow from operating activities totaled 301,552,374.34, up from 292,146,103.29 in Q1 2022, representing an increase of about 3.5%[26] - The cash balance at the end of Q1 2023 was 189,133,303.60, compared to 71,510,129.91 at the end of Q1 2022, marking an increase of approximately 164%[27] - The net increase in cash and cash equivalents for the quarter was 28,205,367.24, contrasting with a decrease of 24,172,687.37 in Q1 2022[27] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,568,884,300.23, a decrease of 0.49% from CNY 1,576,655,152.82 at the end of the previous year[5] - The company's total liabilities decreased to CNY 369,716,183.22 from CNY 429,601,945.44, a reduction of approximately 13.9%[22] - Non-current assets totaled ¥381,327,885.07, down from ¥392,178,194.40, indicating a decrease of about 2.2%[19] - The company's long-term equity investments decreased from ¥104,510,233.07 to ¥95,182,376.66, a decline of approximately 8.5%[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 6,154, with the top ten shareholders holding a combined 62.22% of the shares[10] - The top shareholder, Wu Jianming, holds 16,679,436 shares, representing a significant stake in the company[11] - The total number of shares held by the top 10 unrestricted shareholders includes Shanghai Qianhang Investment Co., Ltd. with 36,900,000 shares, accounting for a significant portion of the company's equity[11] - The company’s stock structure includes a significant portion of shares held by individual investors, reflecting a diverse shareholder base[11] Investment and Growth - The company reported a significant increase in investment income, which rose by 208.87% year-on-year, primarily due to dividends received from Hai Rui[9] - The company has engaged in wealth management with a total investment of 1,200 million RMB in a non-principal guaranteed floating income product, yielding a return of 3.15%[16] - The company has a total of 2,000 million RMB invested in various low-risk wealth management products, with returns ranging from 2.90% to 3.52%[16] - The company plans to continue expanding its market presence and investing in new technologies, although specific figures were not disclosed in the earnings call[21] Employee Stock Ownership Plan - The employee stock ownership plan's second batch was unlocked on February 4, 2023, with a total of 2,150,030 shares released, representing 1.0013% of the company's total share capital of 214,716,125 shares[14] - The third phase of the employee stock ownership plan is still ongoing, with 2,129,860 shares sold through collective bidding, indicating active management of employee incentives[14] - The company plans to continue monitoring the implementation of the employee stock ownership plan and will fulfill disclosure obligations as required by law[14] Operating Costs and Expenses - The total operating costs for Q1 2023 were CNY 200,778,059.68, up from CNY 181,708,840.33, reflecting a growth of 10.5%[22] - Research and development expenses rose to CNY 30,250,472.12, up from CNY 23,809,828.43, reflecting a significant increase of 27.0%[22]